Drugs / OPC-18
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00524498 | Sep 2007 → Jan 2010 | hepatocellular carcinoma | Otsuka Pharmaceutical Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | OPC-18 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00524498 ↗ |
| Route | Subcutaneous | “OPC-18: 500IU \* 3 times a week, sc” NCT00524498 ↗ |